TGFB1 and neoplasm: This is a result of the enhanced secretion of several immunosuppressive molecules, including TGF-β, by the tumor and others factors in the TME, which lead to the impairment of cytotoxic and helper lymphocyte activation, whereas the recruitment of suppressive regulatory T cells is promoted [45].